A caregiver-reported global severity assessment in pediatric atopic eczema: the Comano score.
Atopic dermatitis
Children, Person-centered care
Comano score
Scoring system
Journal
Italian journal of pediatrics
ISSN: 1824-7288
Titre abrégé: Ital J Pediatr
Pays: England
ID NLM: 101510759
Informations de publication
Date de publication:
23 Apr 2020
23 Apr 2020
Historique:
received:
08
08
2019
accepted:
19
03
2020
entrez:
25
4
2020
pubmed:
25
4
2020
medline:
26
2
2021
Statut:
epublish
Résumé
Atopic eczema (AE) is the most common inflammatory skin disease in infancy and its prevalence is rising worldwide. It has a wide social impact on the affected children and their families' lives. AE can have a chronic and heterogeneous course, with periods of remission and relapse of the clinical manifestations. For this reason, its severity assessment through standardized outcome measures becomes a fundamental guide for health professionals, who can manage AE following evidence-based medicine principles in their everyday clinical practice or in clinical trials.Several scoring systems have been recognized to assess the clinical manifestations of AE, both from the physician's and the patient's point of view. Despite the scoring systems standardized for adults, there are very few published options about the expression of a patient/caregiver-centered global severity assessment specifically for pediatric AE. For this reason, the aim of our study was to evaluate a new, quick, user-friendly and feasible caregiver-reported global severity assessment for pediatric AE. Based on a 0-10 numerical rating scale in pediatric AE, we named this scoring system the Comano score.We carried out a cross-sectional observational study enrolling a total of 867 patients aged from 1 to 16 years (males 49.5%, mean patient's age 5.9 years, standard deviation ±3.6 years) with a previous doctor-confirmed diagnosis of AE, who underwent balneotherapy at Comano Thermal Center (Comano, Trentino, Italy). A strong correlation between Comano score and SCORing Atopic Dermatitis (SCORAD) was observed (r = 0.74, p < 0.0001).According to our results, the Comano score may be a promising new tool for the expression of a caregiver-reported global severity assessment in pediatric AE. However, further data are needed to confirm our preliminary findings before health professionals can use this scoring system in their everyday clinical practice to manage pediatric AE. Still, as a patient-focused measure, the Comano score may facilitate delivering person-centered care so as to define a measure for a clinical impact that can be meaningful to the subject, which is gaining importance in modern medicine.
Identifiants
pubmed: 32326955
doi: 10.1186/s13052-020-0805-9
pii: 10.1186/s13052-020-0805-9
pmc: PMC7181490
doi:
Types de publication
Letter
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
50Références
Clin Exp Dermatol. 2009 Jul;34(5):607-12
pubmed: 19508477
Dermatol Ther (Heidelb). 2017 Sep;7(3):383-393
pubmed: 28616853
Br J Dermatol. 2015;172(5):1353-7
pubmed: 25580670
Pediatr Allergy Immunol. 2018 May;29(3):290-295
pubmed: 29350788
J Allergy Clin Immunol. 2013 Dec;132(6):1337-47
pubmed: 24035157
Allergy. 2011 Aug;66(8):1114-21
pubmed: 21414011
Dermatology. 1997;195(1):10-9
pubmed: 9267730
Allergy. 2018 Feb;73(2):451-458
pubmed: 28905999
Br J Dermatol. 2020 Jan;182(1):104-111
pubmed: 30972740
J Allergy Clin Immunol. 2009 Dec;124(6):1251-8.e23
pubmed: 20004783
Br J Dermatol. 2013 Dec;169(6):1326-32
pubmed: 24024631